Mike Evers, Author at ORTHOWORLD

Smith+Nephew Held Back by Strategic Execution and Supply Chain

The company declined in the mid-single digits in 2Q22 as disruption in China exacerbated existing execution and supply problems.

Aug 01, 2022

The company grew in the double digits for 2Q22 with modest declines in the U.S. offset by strength in Europe, Canada and Latin America.

Jul 29, 2022

The company grew in the low single digits for 2Q22 as it contends with slower OUS markets and evolving dynamics in robotics sales.

Jul 28, 2022

The company's second-quarter sales declined in the low single digits as it faced a strong prior year comparison and OUS disruption.

Jul 20, 2022

This month’s chart segments the 239 unique funding announcements we’ve covered since 2016, ranging from IPOs to small grants.

Jul 18, 2022

Executives from some of the largest orthopedic companies gathered at OMTEC to discuss the operating environment and trends.

Jun 27, 2022

The webinar provides company performance analysis and essential takeaways for all segments of the orthopedic market in 2021.

Jun 24, 2022

The orthopedic market is navigating a time of significant change as slow-developing trends start reaching critical mass.

Jun 23, 2022

Knee replacement, hip replacement and spine have been the most susceptible to disruption from procedure cancelations during the pandemic.

Jun 15, 2022

We estimate orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable.

Jun 02, 2022